Physician profile
Anweshan Samanta
NPI 1902260946
$23,836.13
in general payments reported to CMS, 2019-2025
12 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $99.89 · 2021: $126 · 2022: $156 · 2023: $5,062 · 2024: $748 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $14K · Travel and Lodging: $4,976 · Food and Beverage: $4,155 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $14,121.21 |
| Travel and Lodging | $4,975.52 |
| Food and Beverage | $4,155.13 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13,991.49 | 2023-2025 | Mitraclip, Xience Skypoint, Perclose Prostyle |
| Medtronic, INC. | $5,292.53 | 2021-2025 | Onyx Frontier, Ffrangio, Symplicity G3 |
| Edwards Lifesciences Corporation | $2,936.43 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Shockwave Medical, INC | $300.47 | 2025 | |
| Teleflex LLC | $295.05 | 2024-2025 | Guardian, Trapliner, Manta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $287.21 | 2020-2023 | Lifevest |
| Boston Scientific Corporation | $244.24 | 2021-2024 | |
| Abiomed | $175.07 | 2022-2024 | Impella |
| Acorda Therapeutics, INC | $102.34 | 2019 | |
| Ucb, INC. | $100.00 | 2019 | |
| Chiesi USA, INC. | $92.71 | 2024 | Kengreal |
| Janssen Pharmaceuticals, INC | $18.59 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anweshan Samanta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.